Device type · QXO
Cardiovascular Machine Learning-Based Notification Software
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QXO
Cardiovascular
Device class
Class II
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Cardiovascular Machine Learning-Based Notification Software
- Product code
- QXO
- Device class
- Class II
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2380
- Specialty
- Radiology & Imaging, Cardiology, Imaging AI & Software
- FDA record
- Classification database entry for QXO
Latest FDA decisions
- EchoNextBreakthrough510(k)
K260332 · Decided Jun 8, 2026 · 126 days after receipt
Device type: Cardiovascular Machine Learning-Based Notification Software (QXO) · Cardiology
- Viz HCMNew device typeDe Novo
DEN230003 · Decided Aug 3, 2023 · 205 days after receipt
Device type: Cardiovascular Machine Learning-Based Notification Software (QXO) · Cardiology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recalls for this product code in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.